Medicare Enrolled

Dr. Adolfo Fernandez-Obregon, M.D.

Optician · Hoboken, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
10 CHURCH TWRS, Hoboken, NJ 07030
2017953376
In practice since 2005 (21 years)
NPI: 1316944051 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fernandez-Obregon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fernandez-Obregon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fernandez-Obregon

Dr. Adolfo Fernandez-Obregon is an optician specialist in Hoboken, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Fernandez-Obregon performed 1,569 Medicare services across 738 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fernandez-Obregon received a total of $59,165 from 43 pharmaceutical and/or device companies across 799 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fernandez-Obregon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 39% volume in NJ $59,165 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,569
Medicare services
Top 39% in NJ for optician
738
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
556 $72 $140
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
430 $5 $50
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
128 $51 $100
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
108 $95 $250
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
72 $49 $105
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
68 $150 $450
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
59 $80 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
56 $103 $165
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
52 $84 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $131 $215
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$59,165
Total received (2018-2024)
Avg $8,452/year across 7 years
Top 4% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
799
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,550 (63.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,858 (25.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,756 (11.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,485
2023
$10,929
2022
$3,835
2021
$2,249
2020
$7,384
2019
$1,611
2018
$24,673

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$3,299
Janssen Biotech, Inc.
$2,436
Lilly USA, LLC
$432
E.R. Squibb & Sons, L.L.C.
$336
Amgen Inc.
$223
ABBVIE INC.
$197
UCB, Inc.
$188
Novartis Pharmaceuticals Corporation
$187
GENZYME CORPORATION
$186
Incyte Corporation
$178
SUN PHARMACEUTICAL INDUSTRIES INC.
$135
Ortho Dermatologics, a division of Bausch Health US, LLC
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
Verrica Pharmaceuticals Inc.
$106
Regeneron Healthcare Solutions, Inc.
$96
Galderma Laboratories, L.P.
$74
Almirall LLC
$60
Janssen Scientific Affairs, LLC
$43
LEO Pharma Inc.
$31
Dermavant Sciences, Inc.
$17
Arcutis Biotherapeutics, Inc.
$16
Journey Medical Corporation
$15
Top 3 companies account for 72.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$28,974
Amgen Inc.
$6,647
UCB, Inc.
$4,770
Novartis Pharmaceuticals Corporation
$3,766
Janssen Biotech, Inc.
$3,581
Lilly USA, LLC
$1,544
E.R. Squibb & Sons, L.L.C.
$996
LEO Pharma Inc.
$787
Ortho Dermatologics, a division of Bausch Health US, LLC
$721
Sun Pharmaceutical Industries Inc.
$689
Incyte Corporation
$632
Regeneron Healthcare Solutions, Inc.
$603
Galderma Laboratories, L.P.
$561
ABBVIE INC.
$515
Almirall LLC
$514
NOVARTIS PHARMACEUTICALS CORPORATION
$459
GENZYME CORPORATION
$423
AbbVie, Inc.
$384
SUN PHARMACEUTICAL INDUSTRIES INC.
$272
AbbVie Inc.
$272
Journey Medical Corporation
$263
Dermavant Sciences, Inc.
$262
Janssen Scientific Affairs, LLC
$251
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
Celgene Corporation
$148
Kyowa Kirin, Inc.
$119
Verrica Pharmaceuticals Inc.
$106
Arcutis Biotherapeutics, Inc.
$106
Mayne Pharma Inc.
$95
Sebela Pharmaceuticals Inc.
$79
EPI Health, LLC
$78
SANOFI-AVENTIS U.S. LLC
$59
MAYNE PHARMA INC.
$55
MAYNE PHARMA COMMERCIAL LLC
$49
Sandoz Inc.
$48
Aclaris Therapeutics, Inc.
$37
Biofrontera Inc.
$34
Taro Pharmaceuticals USA, Inc.
$31
Merck Sharp & Dohme Corporation
$23
Genentech USA, Inc.
$18
Exeltis, USA Inc.
$14
DERMIRA, INC.
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 68.3% of all-time payments
Associated products mentioned in payments ›
0.25% · ADBRY · AKLIEF · AMELUZ · APEXICON E · ARAZLO · Absorica LD · Ameluz · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EUCRISA · Ecoza · Enbrel · Finacea · HUMIRA · Humira · ILUMYA · Ilumya · JUBLIA · JUBLIA EFINACONAZOLE · Klisyri · LIBTAYO · NAFTIN · OLUMIANT · OPZELURA · ORACEA · Otezla · PICATO · Poteligeo · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TargaDox · Tremfya · VTAMA · Winlevi · XELJANZ · Xolair · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for optician in NJ.

Looking for an optician specialist in Hoboken?
Compare opticians in the Hoboken area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
15,164
Per 100K population
2134.3
County median income
$90,032
Nearest hospital
CAREPOINT HEALTH-HOBOKEN UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fernandez-Obregon is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of NJ peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fernandez-Obregon experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Fernandez-Obregon performed 556 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fernandez-Obregon receive payments from pharmaceutical companies?
Yes. Dr. Fernandez-Obregon received a total of $59,165 from 43 companies across 799 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fernandez-Obregon's costs compare to other opticians in Hoboken?
Dr. Fernandez-Obregon's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fernandez-Obregon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →